Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma
- PMID: 24367679
- PMCID: PMC3867505
- DOI: 10.1371/journal.pone.0084586
Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma
Abstract
Purpose: To analyze the clinicopathological characteristics, treatment modalities, and potential prognostic factors of radiation-related second malignant neoplasms (SMNs) in a large group of nasopharyngeal carcinoma (NPC) cases.
Methods and materials: Institutional electronic medical records of 39,118 patients with NPC treated by definitive radiotherapy between February 1964 and December 2003 were reviewed. A total of 247 patients with confirmed SMN attributable to radiotherapy were included.
Results: Median latency between radiotherapy for NPC and the diagnosis of SMN was 9.5 years (range, 3.1-36.8 years). Squamous cell carcinoma was the most common histologic type, followed by fibrosarcoma and adenocarcinoma. Median progression-free survival and overall survival (OS) of the 235 patients who underwent treatment were 17.3 months and 28.5 months, respectively. The 5-year OS rates were 42.9%, 23.7%, and 0% for the surgery, radiotherapy, and chemotherapy groups, respectively. The independent prognostic factors associated with survival were sex, histologic type, and treatment modality in both the early stage subgroup and the advanced stage subgroup of SMN.
Conclusions: Sex, histologic type, and treatment modality were the significant prognostic factors for SMN. Complete resection offers the best chance for long-term survival. In select patients with locally advanced and unresectable SMN, reirradiation should be strongly considered as a curative option.
Conflict of interest statement
Figures
Similar articles
-
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1099-111. doi: 10.1016/s0360-3016(98)00164-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9719121
-
Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma.Chin J Cancer. 2016 Oct 12;35(1):89. doi: 10.1186/s40880-016-0153-8. Chin J Cancer. 2016. PMID: 27729091 Free PMC article.
-
The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.Cancer. 2006 Sep 15;107(6):1287-93. doi: 10.1002/cncr.22119. Cancer. 2006. PMID: 16909425
-
Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.Cancer Res Treat. 2019 Jul;51(3):982-991. doi: 10.4143/crt.2018.298. Epub 2018 Oct 11. Cancer Res Treat. 2019. PMID: 30309219 Free PMC article.
-
How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. doi: 10.1016/s0360-3016(97)00854-7. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531376 Review.
Cited by
-
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity.Discov Oncol. 2024 May 16;15(1):170. doi: 10.1007/s12672-024-01011-2. Discov Oncol. 2024. PMID: 38753073 Free PMC article. Review.
-
Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.Cancer Res Treat. 2017 Jul;49(3):695-705. doi: 10.4143/crt.2016.317. Epub 2016 Oct 11. Cancer Res Treat. 2017. PMID: 27737535 Free PMC article.
-
The risk of second primary cancer after nasopharyngeal cancer: a systematic review.Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4775-4781. doi: 10.1007/s00405-023-08144-0. Epub 2023 Jul 26. Eur Arch Otorhinolaryngol. 2023. PMID: 37495725 Free PMC article.
-
Diabetes and two kinds of primary tumors in a patient with thalassemia: a case report and literature review.Front Oncol. 2023 Aug 11;13:1207336. doi: 10.3389/fonc.2023.1207336. eCollection 2023. Front Oncol. 2023. PMID: 37637036 Free PMC article.
-
The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.Cancer Med. 2018 Apr;7(4):1056-1069. doi: 10.1002/cam4.1348. Epub 2018 Feb 26. Cancer Med. 2018. PMID: 29479858 Free PMC article.
References
-
- Palazzi M, Orlandi E, Bossi P, Pignoli E, Potepan P et al. (2009) Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int J Radiat Oncol Biol Phys 74: 774-780. doi:10.1016/j.ijrobp.2008.08.068. PubMed: 19250771. - DOI - PubMed
-
- Lai SZ, Li WF, Chen L, Luo W, Chen YY et al. (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80: 661-668. doi:10.1016/j.ijrobp.2010.03.024. PubMed: 20643517. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources